Mirtazapine and antiretroviral therapy in the treatment of progressive multifocal leukoencephalopathy associated with HIV-1 infection: Report of a case and review of literature;Tratamiento conjunto con mirtazapina y terapia antiretroviral para la leucoencefalopatía multifocal progresiva asociada a infección por VIH-1: Presentación de un caso clínico y revisión de la literatura

Revista Chilena de Infectologia

Volumn 29, Issue 2, 2012, Pages 217-220

  Lasso, Martin ^a   Cerón, Inés ^a  

^a HOSPITAL DR SÓTERO DEL RÍO   (Chile)

Author keywords

HAART; JC virus; Mirtazapine; Progressive multifocal leukoencephalopathy

Indexed keywords

DRUG DERIVATIVE; MIANSERIN; MIRTAZAPINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CASE REPORT; DRUG COMBINATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED DEMENTIA; HUMAN; MALE; METHODOLOGY; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; TREATMENT OUTCOME;

ADULT; AIDS DEMENTIA COMPLEX; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DRUG THERAPY, COMBINATION; HUMANS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MALE; MIANSERIN; TREATMENT OUTCOME;

EID: 84861935384     PISSN: 07161018     EISSN: None     Source Type: Journal    
DOI: 10.4067/S0716-10182012000200016     Document Type: Article

References (26)

1. Padgett B L, Walker D L, Zurhein G M, Eckroade R J, Dessel B H. Cultivation of papova-like virus from human brain with progressive multifocal leukoencephalopathy. The Lancet 1971; 1 (7712): 1257-60.
2. Khanna N, Elzi L, Mueller N J, Garzoni C, Cavassini M, Fux C A, et al. Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study. Clin Infect Dis 2009; 48: 1459-66.
3. Antiretroviral Therapy Cohort Collaboration (ART-CC). Variable impact on mortality of AIDS-defi ning events diagnosed during combination antiretroviral therapy: Not all AIDS-defi ning conditions are created equal. Clin Infect Dis 2009; 48: 1138-51
4. Gasnault J, Kahraman M, de Goër M G, Durali D, Delfraissy J F, Taufi k Y. Critical role of JC virus-specifi c CD4 T cell responses in preventing progressive multifocal leukoencephalopathy. AIDS 2003; 17: 1443-9.
5. thEdition. Philadelphia PA Churchill-Livingston-Elsevier. 2010 p: 2051-8.
6. Lima M A, Drislane F W, Koralnik I J. Seizures and their outcome in progressive multifocal leukoencephalopathy. Neurology 2006; 66 (2): 262-4.
7. Travis J, Varma A, duPlessis D, Turnbull I, Vilar F J. Immune reconstitution associated with progressive leukoencephalopthy in human immunodefi ciency virus: a case discussion and review of the literature. Neurologist 2008; 14 (5): 321-6.
8. Miranda G, Díaz C, Dellien H, Hermosilla H. Enfrentamiento imagenológico de las lesiones cerebrales en pacientes VIH. Rev Chil Radiol 2008; 14 (4): 200-7.
9. Knowles W A, Pipkin P, Andrews N, Vyse A, Minor P, Brown D W, et al. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol 2003; 71 (1): 115-23.
10. Koralnik I J, Boden D, Mai V, Lord C, Letvin N. JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy. Neurology 1999; 52 (2): 253-60.
11. Cinque P, Scarpellini P, Vago L, Linde A, Lazzarin A. Diagnosis of central nervous system complications in HIV-infected patients: cerebrospinal fl uid analysis by the polymerase chain reaction. AIDS 1997; 11 (1): 1-17.
12. Cinque P, Koralnik IJ, Clifford D. The evolving face of progressive multifocal leukoencephalopathy: towards the defi nition of a consensus terminology. J Neurovirol 2003; 9: 88-92.
13. thConference on Retroviruses and Opportunistic Infections. Boston 2008 Abstract 385.
14. thConference on Retroviruses and Opportunistic Infections. San Francisco 2010 Abstract 172.
15. Albrecht H, Hoffmann C, Degen O, Stoehr A, Plettenberg A, Mertenskötter T, et al. Highly active antiretroviral therapy signifi cantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy. AIDS 1998; 12 (10): 1149.
16. Elliot B, Aromin I, Gold R, Flanigan T, Mileno M. 2.5 year remission of AIDSassociated progressive multifocal leukoencephalopathy with combined antiretroviral therapy. Lancet 1997; 349 (9055): 850.
17. Turnher M, Donovan M J, Rieger A, Kleibl-Popov C, Loewe C, Schindler E. Initial and follow-up MR imaging fi ndings in AIDS related progressive multifocal leukoencephalopathy treated with highly active antiretroviral therapy. AJNR 2001; 22: 977-84.
18. Elphick G F, Querbes W, Jordan J A, Gee G V, Eash S, Manley K, et al. The human polyomavirus. Uses serotonin receptors to infect cells. Science 2004; 306 (5700): 1380-3.
19. Baum S, Ashok A, Gee G, Dimitrova S, Querbes W, Jordan J, et al. Early events in the life cycle of JC virus as potential therapeutic targets for the treatment of progressive multifocal leukoencephalopathy. J Neurovirol 2003; 9 (Suppl1): S32-S37.
20. Cettomai D, McArthur J C. Mirtazapine use in human immunodefi ciency virusinfected patients with progressive multifocal leukoencephalopathy. Arch Neurol 2009; 66 (2): 255-8.
21. Lanzafame M, Ferrari S, Lattuada M, Corsini F, Deganello R, Vento S, et al. Mirtazapine in an HIV-1 infected patient with progressive multifocal leukoencephalopathy. Infez Med 2009; 17 (1): 35-7.
22. Vulliemoz S, Lurati-Ruiz F, Borruat F X, Delavelle J, Koralnik I, Kuntzer T, et al. J Favourable outcome of progressive multifocal leucoencephalopathy in two patients with dermatomyositis. Neurol Neurosurg Psychiatry 2006; 77 (9): 1079-82.
23. Owczarczyk K, Hilker R, Brunn A, Hallek M, Rubbert A. Progressive multifocal leucoencephalopathy in a patient with sarcoidosis-successful treatment with cidofovir and mirtazapine. Reumatology (Oxford) 2007; 46 (5): 888-90.
24. Verma S, Cikurel K, Koralnik I, Morgello S, Cunningham-Rundles C, Weinstein Z. Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera. J Infect Dis 2007; 196 (5): 709-11.
25. Chapagain M L, Verma S, Mercier F, Yanagihara R, Nerurkar V R. Polyomavirus JC infects human brain microvascular endotelial cells independent of serotonin receptor 2. Virology 2007; 364 (1): 55-63
26. Chapagain M L, Sumibcay L Gurjav U, Kaufusi P H, Kast R E, Nerurkar V R. Serotonin receptor 2A blocker (risperidone) has no effect on human polyomavirus JC infection of primary human fetal glial cells. J NeuroVirol 2008; 14: 448-54.